Asymptomatic Bacteriuria In Patients With Type-2 Diabetes Mellitus
Asymptomatic Bacteriuria In Patients With Type-2 Diabetes Mellitus
Keywords:
Bacteriuria, Type 2 diabetes mellitus, Escherichia coliAbstract
Background: Diabetic subjects, especially women, show high prevalence of asymptomatic bacteriuria (ASB). The aim of the present study was to evaluate the prevalence of asymptomatic bacteriuria (ASB) in patients with type 2 diabetes mellitus and to find out the antibiotic sensitivity pattern of bacterial isolates. Methods: One hundred and thirty type 2 diabetics comprising 56 males and 74 females (aged between 30 - 59 years) attending the outpatient department of Chhattisgarh Institute of Medical sciences hospital, Chhattisgarh, India was recruited in the study. Mid-stream urines were collected from patients aseptically into sterile wide mouth container and examined microscopically, culturally using standard techniques and tested for glucose, post-prandial glucose, protein and ketone using a dipstick. Samples were cultured on blood agar, McConkey agar and Cysteine Lactose Electrolyte Deficient (CLED) media and incubated at 37°C aerobically for 24 h. Isolates were tested against antibiotics which included tetracycline, chloramphenicol, ciprofloxacin and cotrimoxazole by the disc diffusion method. Results: Significant bacteriuria was observed in Forty-seven (36.15%) of urine samples (34 females and 13 males) . Bacteria isolated included Escherichia coli (56.9%), Enterobacter sp. (12.7%), Klebsiella pneumoniae (8.5%) and Proteus sp. (6.3%). E. coli, Enterobacter sp. K. pneumoniae, S. aureus and Proteus sp. were most sensitive to cotrimazaxole, amoxicillin, nalidixic acid and ciprofloxacin but a large number of bacteria were resistant to tetracycline, chloramphenicol and ampicillin. Conclusion: Screening for ASB is necessary in diabetic patients especially if pyuria is detected in urine analysis since ASB has been found to be a risk factor for developing symptomatic urinary tract infection
References
(2003). Significant asymptomatic bacteriuria
among Nigeria type 2 diabetics. J. Nat. Med.
Assoc. 95(5): 344-348
2. Assel MT, AI-Meer FM, AI-Kuwari MG, Ismail MF
(2009). Prevalence and predictor of
asymptomatic bacteriuria among pregnant
women attending Primary health care in Qatar
Middle East. J. Fam. Med. 4:14-17.
3. Meiland R, Geerlings SE, Stolk RP, Netten PM,
Schechberfor PM, Hoepelman Al (2006).
Asymptomatic bacteriuria in women with
diabetes mellitus: effect on renal function after
6 years of follow- up. Archives Int. Med.
1666(20): 2222-2227.
4. Nicolle LE (2003). Asymptomatic bacteriuria:
when to ereen and when to treat. Infect. Dis.
Clin. North Am. 17: 367-394.
5. Nicolle LE (2005). Urinary tract infection in
diabetes. Curr. Opin. Infect.Dis. 18(1): 49-53.
6. Stapleton A (2002). Urinary tract infections in
patients with diabetes. Am. J. Med. 113(1): 805-
845.
7. 7. Olaitan JO (2006). Asymptomatic
bacteriuria in female students population of
a Nigeria University. Int. J. Microbiol. 2(2): 4-9.
8. Dylan AT, Chua JA (1999). Surveillance of
pathogens and resistance patterns in urinary
tract infections. Phil. J. Microbiol. Infect. Dis.
28(1): 11-14.
9. Baqai R, Aziz M, Rasool G (2008). Urinary tract
infection in diabetics patients and biofilm
formation of uropathogens. Infect. Dis. J.
Pak.17(1): 21-24.
10. Uncu Y, Uncu G, Esmer A, Bilgel N (2002).
Should asymptomatic bacteriuria be screened
in pregnancy? Clin. Exp. Obt. Gyneco. 29(4):
281-285.
11. Hajeri A (2008). When to treat asymptomatic
bacteriuria. Bahrain. Med. Bull. 30(2): 1-4.
12. Flower CH, Levett PN, Singh S, Fraser HS
(1991). Prevalence of asymptomatic bacteriuria
in diabetic females in Barbados 40(1): 34.
13. Harding GK, Zhanel GG, Nicolle LE, Cheang M
(2002). Antimicrobial treatment in Diabetic
women with asymptomatic bacteriuria N. Engl.
J. Med. 347:1576-1583.
14. Bucchanan RE, Gibbons ME (1974).
Sergey's Mannual for Determinative
Bacteriology (8lh) Williams and Wilkins
Baltimaore, USA.
15. National Committee for Clinical Laboratory
Standards. 1999. Performance standards for
antimicrobial susceptibility testing. NCCLS
approved standard; M100-S9, M100-S10, M7-
A5, M7-A4. National Committee for Clinical
Laboratory Standards, Wayne, PA.
16. Johnson JR (2003). Microbial virulence
determinants and the pathogenesis of
Urinary tract infection. Infect. Dis. Clin. North.
Am. 17:261-265.
17. Olusanya N, Olutiola PO (1984). Studies of
bacteriuria in patients and students, in lle-lfe,
Nigeria. West Afr. J. Med. 3(3): 177-183.
